LifeStance Health Group, Inc. [Rocket]

Overview

LifeStance Health Group, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/03/2023	4	Mullins Kevin Michael (Chief Development Officer) has filed a Form 4 on LifeStance Health Group, Inc.
10/02/2023	144	Form 144 - Report of proposed sale of securities:
09/27/2023	3	Cipollone Paula (See Remarks) has filed a Form 3 on LifeStance Health Group, Inc.
08/25/2023	4	Varanakis Ann (Chief People Officer) has filed a Form 4 on LifeStance Health Group, Inc.
08/09/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/08/2023	8-K	Quarterly results
07/20/2023	144	Form 144 - Report of proposed sale of securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-19
Revenues	859.5	667.5	212.5
Revenue growth	28.8%
Cost of goods sold	0.0	0.0	0.0
Gross profit	859.5	667.5	212.5
Gross margin	100.0%	100.0%	100.0%
Selling, general and administrative	378.0	433.7
General and administrative			41.1
EBITA	-170.6	-251.1	13.1
EBITA margin	-19.8%	-37.6%	6.1%
Amortization of intangibles	40.3	39.0
EBIT	-210.9	-290.1	13.1
EBIT margin	-24.5%	-43.5%	6.1%
Pre-tax income	-232.7	-333.1	7.9
Income taxes	-17.2	-25.9	-2.2
Tax rate	7.4%	7.8%
Net income	-215.6	-343.9	0.0
Net margin	-25.1%	-51.5%	0.0%

Diluted EPS	($0.61)	($1.05)
Shares outstanding (diluted)	355.3	327.5

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.